[Research on COVID-19 vaccination strategies in Singapore]

Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Mar 10;43(3):310-314. doi: 10.3760/cma.j.cn112338-20211125-00919.
[Article in Chinese]

Abstract

As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore's National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China.

截至2021年12月31日,新加坡累计报告已有4 758 601人完成至少一剂次新型冠状(新冠)病毒疫苗接种,4 714 655人完成两剂次新冠病毒疫苗接种,2 207 341人完成新冠病毒疫苗加强针接种。本研究通过深入分析新加坡新冠病毒疫苗接种现状,解读新加坡国家疫苗接种计划内容,系统梳理新加坡新冠病毒疫苗上门接种、疫苗接种差异化管理、拒绝接种疫苗者感染新冠病毒后自付医药费等具体措施,为我国新冠病毒疫苗接种工作提供参考。.

MeSH terms

  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Humans
  • Immunization Programs
  • Singapore
  • Vaccination

Substances

  • COVID-19 Vaccines